VPPRN Co-Principal Investigator Jennifer Gordon is currently serving as the co-Lead Patient-Partner in the EGPA Registry. Dr. Gordon was diagnosed with EGPA, a form of ANCA-associated vasculitis, in 2014. She holds a Ph.D. in Pathology and spent the last 30 years working as an NIH-funded biomedical researcher studying neurological disorders and infectious diseases, most recently as an Associate Professor in the Department of Neuroscience at Temple University School of Medicine in Philadelphia, Pennsylvania. She recently retired from academia and is now consulting at Excision BioTherapeutics, a biotech start-up company developing CRISPR-based gene editing for the treatment of HIV and other viral diseases. Jenn is active in the vasculitis community. She is a patient partner in the Vasculitis Patient Powered Research Network (VPPRN) and a member of the VPPRN-VCRC EGPA Registry Joint Steering Committee. She currently hosts the EGPA Café Zoom Chat through the Vasculitis Foundation. You can find her blog online at www.vasculitides.com or follow her on Twitter at @vasculitides.